✦ LIBER ✦

Involvement of serum amyloid P component and C-reactive protein in the pathogenesis of Alzheimer's disease

✍ Scribed by Veerhuis, Robert; Janssen, Ingrid; Van Muiswinkel, Freek L.; Eikelenboom, Piet

Book ID: 122938398
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 168 KB
Volume: 21
Category: Article
ISSN: 0197-4580
DOI: 10.1016/S0197-4580(00)83145-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isolation of human C-reactive protein an

Isolation of human C-reactive protein and serum amyloid P component

✍ F.C. De Beer; M.B. Pepys 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 783 KB

Rapid isolation of human C reactive prot

Rapid isolation of human C reactive protein and serum amyloid P component

✍ Kohzo Hashimoto; Noriyuki Tatsumi 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 100 KB

The major acute phase reactants: C-react

The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein

✍ Diana M. Steel; Alexander S. Whitehead 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 751 KB

Amyloid β protein precursor and the path

Amyloid β protein precursor and the pathogenesis of Alzheimer's disease

✍ Selkoe, Dennis J. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Promotion of β-amyloid production by C-r

Promotion of β-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer’s disease

✍ Bing-Tian Bi; Huan-Bing Lin; Yu-Fang Cheng; Heng Zhou; Ting Lin; Ming-Zi Zhang; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 912 KB

Structural basis of ligand specificity i

Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component

✍ Halina Mikolajek; Simon E. Kolstoe; Valerie E. Pye; Palma Mangione; Mark B. Pepy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

## Abstract The normal physiological roles of the phylogenetically conserved human plasma proteins C‐reactive protein (CRP) and serum amyloid P component (SAP) are not known. Novel drugs targeting their ligand specificities are in clinical development as both proteins have significant pathophysiolo